Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Other Accumulated Expenses (2016 - 2020)

Historic Other Accumulated Expenses for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $81000.0.

  • Forte Biosciences' Other Accumulated Expenses fell 9542.63% to $81000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $81000.0, marking a year-over-year decrease of 9542.63%. This contributed to the annual value of $2000.0 for FY2019, which is 9987.72% down from last year.
  • As of Q3 2020, Forte Biosciences' Other Accumulated Expenses stood at $81000.0, which was down 9542.63% from $133000.0 recorded in Q2 2020.
  • Forte Biosciences' 5-year Other Accumulated Expenses high stood at $2.2 million for Q2 2019, and its period low was $2000.0 during Q4 2019.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $823000.0 (2017), whereas its average is $970812.5.
  • As far as peak fluctuations go, Forte Biosciences' Other Accumulated Expenses surged by 22972.54% in 2018, and later plummeted by 9987.72% in 2019.
  • Quarter analysis of 5 years shows Forte Biosciences' Other Accumulated Expenses stood at $312000.0 in 2016, then skyrocketed by 199.04% to $933000.0 in 2017, then soared by 74.6% to $1.6 million in 2018, then plummeted by 99.88% to $2000.0 in 2019, then skyrocketed by 3950.0% to $81000.0 in 2020.
  • Its Other Accumulated Expenses was $81000.0 in Q3 2020, compared to $133000.0 in Q2 2020 and $344000.0 in Q1 2020.